$PHIO Phio Pharmaceuticals Corp. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Phio Pharmaceuticals Corp..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Phio Pharmaceuticals Corp.. Insider overview, share value development, latest insider transactions and email notifications about new events in Phio Pharmaceuticals Corp. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PHIO
Company Address: 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH 01752
Phone number: 508-767-3861
Former name: RNCS, INC.
Former name: RXi Pharmaceuticals Corp, date of change: 2011-10-19
Former name: RXI Pharmaceuticals Corporation
Market Capitalization: $4.88M
Prev close: $0.64
Average Daily Volume: 894,160
Days Low: $0.62
Year Low: $0.60
Year High: $3.27
Phio Pharmaceuticals Corp. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2021 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Buy | P | 2.56 | 1,953 | 5,000 | 89,281 | 87.3 K to 89.3 K (+2.24 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Director | Grant | A | 0.00 | 10,000 | 0 | 22,822 | 12.8 K to 22.8 K (+77.99 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Dorman H. Paul | Director | Grant | A | 0.00 | 10,000 | 0 | 10,370 | 370 to 10.4 K (+2,702.70 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Freeman Jonathan E | Director | Grant | A | 0.00 | 10,000 | 0 | 10,364 | 364 to 10.4 K (+2,747.25 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 10,366 | 366 to 10.4 K (+2,732.24 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Bitterman Robert J | Director | Grant | A | 0.00 | 10,000 | 0 | 15,826 | 5.8 K to 15.8 K (+171.64 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Ferrara Robert L | Director | Buy | P | 3.15 | 682 | 2,148 | 13,000 | 12.3 K to 13 K (+5.54 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Ferrara Robert L | Director | Grant | A | 0.00 | 10,000 | 0 | 12,318 | 2.3 K to 12.3 K (+431.41 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Buy | P | 3.03 | 2,500 | 7,575 | 87,328 | 84.8 K to 87.3 K (+2.95 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Grant | A | 0.00 | 68,450 | 0 | 84,828 | 16.4 K to 84.8 K (+417.94 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Kontulis Caitlin | Secretary & VP Fina ... | Grant | A | 0.00 | 34,600 | 0 | 39,826 | 5.2 K to 39.8 K (+662.07 %) |
| Aug 19 2020 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Buy | P | 2.50 | 2,000 | 5,000 | 16,377 | 14.4 K to 16.4 K (+13.91 %) |
| Mar 03 2020 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Payment of Exercise | F | 2.93 | 673 | 1,972 | 14,628 | 15.3 K to 14.6 K (-4.40 %) |
| Nov 20 2019 | PHIO | Phio Pharmaceutica ... | Bitterman Robert J | Director | Grant | A | 0.10 | 300,000 | 30,000 | 320,440 | 20.4 K to 320.4 K (+1,467.71 %) |
| Nov 20 2019 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Grant | A | 0.10 | 350,000 | 35,000 | 827,817 | 477.8 K to 827.8 K (+73.25 %) |